CN1682869A - Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure - Google Patents

Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure Download PDF

Info

Publication number
CN1682869A
CN1682869A CNA2005100240186A CN200510024018A CN1682869A CN 1682869 A CN1682869 A CN 1682869A CN A2005100240186 A CNA2005100240186 A CN A2005100240186A CN 200510024018 A CN200510024018 A CN 200510024018A CN 1682869 A CN1682869 A CN 1682869A
Authority
CN
China
Prior art keywords
preparation
chinese medicine
antler
colla cornus
cervi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2005100240186A
Other languages
Chinese (zh)
Other versions
CN100333746C (en
Inventor
徐德生
刘力
胡婉英
罗月琴
唐岚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shuguang Hospital Affiliated to Shanghai University of TCM
Original Assignee
Shanghai Zhongda Shuguang Medical Research And Development Co ltd
Shuguang Hospital Affiliated to Shanghai University of TCM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Zhongda Shuguang Medical Research And Development Co ltd, Shuguang Hospital Affiliated to Shanghai University of TCM filed Critical Shanghai Zhongda Shuguang Medical Research And Development Co ltd
Priority to CNB2005100240186A priority Critical patent/CN100333746C/en
Publication of CN1682869A publication Critical patent/CN1682869A/en
Application granted granted Critical
Publication of CN100333746C publication Critical patent/CN100333746C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The Chinese medicine preparation for treating chronic heart failure is prepared with the Chinese medicinal materials antler glue or antler tablet, epimedium, privet fruit, malaytea scurfpea fruit, dogwood and dried orange peel in certain proportion. The preparation process includes decocting the medicine materials except antler glue or antler tablet, high speed centrifuging to eliminate impurity, concentrating the supernatant, spray drying to obtain extractum powder, adding antler powder and supplementary material, and preparing oral preparation via conventional process. The Chinese medicine preparation has high active component content, determined curative effect and easy preparation, and is suitable for industrial production.

Description

A kind of preparation method for the treatment of the Chinese medicine preparation of chronic heart failure
Technical field
The present invention relates to the field of Chinese medicines.Be specifically related to a kind of preparation method for the treatment of the Chinese medicine preparation of chronic heart failure.
Background technology
Congestive heart failure (CHF) is a kind of syndrome that multiple heart disease finally all will take place, and infers that according to the Framingham research data China has the patients with heart failure more than 10,000,000 approximately, and annual morbidity is about 3~4 ‰, is a kind of common frdquently encountered disease kind.Medicine commonly used clinically at present is diuretic, digitalis type cardiac glycosides and vasodilator, but effect is all comprehensive or existence toxicity, side effect in various degree.The Chinese medicine medicine that is used for anti-chronic heart failure still lacks.Therefore as the market demand, the new Chinese medicine of relevant anti-heart failure will have the wide development prospect, have bigger market, from preventing treatment, considerable economic be arranged.And there is no ideal treatment chronic heart failure oral Chinese medicine (comprising natural drug) listing at present both at home and abroad.
Cornu Cervi side's (in high spirit preparation) is the pure Chinese medicinal preparation of a kind of CHF of treatment.By animal pattern hemodynamics, oxygen-derived free radicals, myocardial cell Na-K-ATP enzymatic activity, Endothelin, nitric oxide (NO) and synthase (NOS) mRNA thereof, Angiotensin II and I receptor mRNA thereof are expressed, the research of neonatal rat myocardial cell cytosolic free calcium and ventricular weight influence, tentatively proved Cornu Cervi side's (in high spirit preparation) have positive inotropic action and may with open L type Ca 2+Passage is relevant; Tool antioxidant radical, thereby cardiac function protecting; The endocrine regulation factor delays or blocks effects such as left ventricular remodeling.Cornu Cervi side's (in high spirit preparation) is according to the theory of motherland's medical science " coordinating water and fire, heart kidney is correlated with ", and the academic thought of " kidney is returned in prolonged illness ", " control the heart and why control kidney; " so and control kidney and just controlling the heart, treat congestive heart failure with tonifying kidneys, strengthening heart ruling by law, in clinical practice more than ten years, the chronic heart failure for the treatment of each stage has definite curative effect.
Existing Cornu Cervi side (in high spirit preparation) preparation method adopts decoction and alcohol sedimentation technique to extract active ingredient usually, and the 7th phase P619-621 discloses Cornu Cervi side Study on extraction process result as " Chinese Journal of New Drugs " 2004 the 13rd volumes.
Summary of the invention
Technical problem to be solved by this invention is existing Cornu Cervi side (in high spirit preparation) active ingredient extracting method is improved, a kind of active ingredient content height is provided, the preparation solid preparation is convenient, and the quality of the pharmaceutical preparations is stable, the method for preparing Cornu Cervi square preparation (in high spirit preparation) of determined curative effect.
The preparation method of the Chinese medicine preparation of treatment chronic heart failure disclosed by the invention (the Cornu Cervi square preparation has another name called in high spirit preparation) comprises the following steps:
1, raw material weight percentage ratio prescription
Colla cornus cervi 1%-5% or Cornu Cervi tablet 8%-25%, Herba Epimedii 15%-40%, Fructus Ligustri Lucidi 15%-40%, Fructus Psoraleae 10%-30%, Fructus Corni 8%-25% and Pericarpium Citri Reticulatae 8%-25%;
2, preparation method
Get Colla cornus cervi or Cornu Cervi tablet and pulverize, cross 80 mesh sieves, standby; Getting all the other components in the prescription adds the water that 10-30 doubly measures and decocts 2-3 time for 90 ± 10 ℃, filter, collecting decoction, being concentrated into relative density is 1.04-1.05 (room temperature), the 14000-16000rps high speed centrifugation, getting supernatant concentration to relative density is 1.10-1.14 (90 ℃), spray drying or add a small amount of dextrin spray drying and get extract powder; Above-mentioned harts horn carbon is mixed with extract powder, and adding pharmaceutic adjuvant formulation method is routinely made solid orally ingestible;
Or get in the prescription except that Colla cornus cervi each raw material and add the water that 10-30 doubly measures and decoct 2-3 time filtration, collecting decoction for 90 ± 10 ℃, the 14000-16000rps high speed centrifugation, get supernatant concentration, adding preservative agent, correctives or the Colla cornus cervi after molten are made mixture according to a conventional method.
Each oral formulations of the present invention comprises granule and mixture etc., takes icariin content every day greater than 54mg/g, and psoralen is greater than 42mg/g.
The inventor finds that through repetition test the active ingredient that prior art adopts the water extract-alcohol precipitation method to extract in the Cornu Cervi side can make main active ingredient icariin and psoralen lose more.With Cornu Cervi side's (in high spirit preparation) each component (except the Colla cornus cervi) decocting liquid 90 ℃ the time is example with 70% precipitate with ethanol and high speed centrifugation method of the present invention remove impurity respectively, and the active ingredient result is compared as follows table:
Impurity-removing method icariin content reduces psoralen content and reduces the minimizing of isopsoralen content
(%)?????????????(%)???????????????(%)
70% precipitate with ethanol 14.72 20.79 20.84
High speed centrifugation 9.41 14.17 16.91
The above results shows that decoction and alcohol sedimentation technique makes active ingredient, and particularly the icariin content loss is more, and adopts decocting liquid of the present invention through centrifugal impurity removal process, can effectively reduce the loss of active ingredient, extracts active ingredient to greatest extent.
In addition compared with prior art, the extract of the inventive method acquisition is convenient to the preparation of solid preparation.When extract of the present invention was prepared into solid preparation, usually extracting solution must the spray-dried extract powder that becomes, and granulate, thereby supplementary product consumption in the minimizing preparation reduces clinical taking dose again.If the sample liquid behind the water extract-alcohol precipitation is carried out spray drying, very easily sticking wall is difficult to obtain dried powder, and loss is very big, even obtain powder, because of hygroscopicity is very strong, also is difficult to make granule, makes troubles for the preparation of solid preparation.And the present invention through ultracentrifugal medicinal liquid because to remove impurity comparatively thorough, concentrate, after the spray drying, can obtain dry loose powdered, the back yield rate height of granulating can be suitable for large-scale production.
Chinese medicine preparation of the present invention is specially adapted to treat Chinese medical discrimination and belongs to the chronic heart failure of suffering from a deficiency of the kidney.
Carried out toxicity test with Chinese medicine preparation of the present invention: acute toxicity, the maximum tolerated dose of irritating the stomach mice is crude drug 212g crude drug/kg; Long term toxicity, the high, medium and low dosage group of granule compares with blank group, and the overt toxicity reaction is not seen in administration in continuous six months.Prove that preparation of the present invention is safe in utilization.
By Chinese medical discrimination suffer from a deficiency of the kidney standard and the diagnostic criteria of doctor trained in Western medicine Framingham heart failure, carry out clinical research with the mixture and the granule of extract preparation of the present invention to going into to organize patient, every group 40 example, the result shows:
Preparation of the present invention can significantly improve CHF patient's NYHA cardiac functional grading (obvious effective rate 47%, total effective rate 87%) and the scoring of Lee heart failure, and its curative effect and captopril and digoxin matched group are similar substantially.Simultaneously we can also significantly improve CHF patient's symptom integral of suffering from a deficiency of the kidney, thereby the prompting Chinese medicine especially has one's own knack aspect CHF patient's clinical symptoms improving on treatment CHF really.On the index that ultrasoundcardiogram detected, can see, compare with the digoxin matched group, after taking preparation of the present invention, can significantly improve CHF patient's IVST, PWT, EF, CO, FS, LVMI (P<0.05), especially the reduction of IVST, PWT, LVMI, in conjunction with the improvement of patient's cardiothoracic ratio, illustrate that we can strengthen myocardium shrinkage function (improving the biological function of cardiac muscle), can suppress or reverse the development of cardiac remodeling again simultaneously.To secular reparation characteristic index, improvement is in various degree arranged all from the hemodynamic index of short-term.This also meets the direction of present heart failure treatment very much: not only improve symptom, improve the quality of living, the more important thing is the mechanism at cardiac remodeling, prevent or delay the development of cardiac remodeling, thereby reduce the mortality rate and the admission rate of heart failure.
Comprehensively above-mentioned, as to adopt the inventive method to prepare Cornu Cervi square preparation, active ingredient content height, preparation is convenient, determined curative effect, this method is particularly suitable for industrialization production.
The specific embodiment
Embodiment 1 in high spirit particulate preparation
1. get Colla cornus cervi 2.5kg and pulverize, cross 80 mesh sieves, standby.
2. get Herba Epimedii 25kg, Fructus Ligustri Lucidi 20kg, Fructus Psoraleae 25kg, Fructus Corni 15kg, Pericarpium Citri Reticulatae 10kg, the water that at every turn adds 10 times of amounts decocts three times for 90 ℃, first, each 1 hour for the second time, filter the 3rd half an hour, merges three times decocting liquid, being concentrated into relative density is 1.04-1.05 (room temperature), the 16000rps high speed centrifugation, getting supernatant concentration to relative density is 1.10-1.14 (90 ℃), adds an amount of dextrin, spray drying gets extract powder, add the Cornu Cervi rubber powder again, an amount of dextrin and correctives, mixing is with 85% alcohol granulation that contains 2%PVP, dry, get granule 36kg, granulate, packing.Wherein icariin content is 2.22mg/g, and psoralen is 0.76mg/g.
Embodiment 2 in high spirit particulate preparations
1. get Colla cornus cervi 3kg and pulverize, cross 80 mesh sieves, standby.
2. Herba Epimedii 30kg, Fructus Ligustri Lucidi 30kg, Fructus Psoraleae 20kg, Fructus Corni 15kg, Pericarpium Citri Reticulatae 15kg add 100 ℃ of extractions of water, totally three times, first, second time each 1 hour, filters the 3rd half an hour, merge three times decocting liquid, the 14000rps high speed centrifugation, getting supernatant concentration to relative density is 1.10-1.14 (90 ℃), spray drying gets extract powder, add Cornu Cervi rubber powder and an amount of dextrin, mixing, the dried grain that extrudes, get granule 30kg, packing.Wherein icariin content is 3.58mg/g, psoralen 0.82mg/g.
Embodiment 3 in high spirit particulate preparations
1. get Colla cornus cervi 2.2kg and pulverize, cross 100 mesh sieves, standby.
2. get Herba Epimedii 25kg, Fructus Ligustri Lucidi 22kg, Fructus Psoraleae 18kg, Fructus Corni 13kg, Pericarpium Citri Reticulatae 13kg, add water and decoct secondary, each 1 hour for 100 ℃, filter, merge the secondary decocting liquid, be concentrated into an amount of, the 16000rps high speed centrifugation, getting supernatant concentration to relative density is 1.12 (90 ℃), adds an amount of dextrin, mixing, spray drying gets extract powder, adds Cornu Cervi rubber powder and an amount of dextrin, fluidized granulation, get granule 30kg, packing.Wherein icariin content is 2.82mg/g, and psoralen is 0.70mg/g.
Embodiment 4 icariin HPLC assays
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Methanol-water (55: 45) is a mobile phase; Detect wavelength 270nm.
It is an amount of that the preparation precision of reference substance solution takes by weighing the icariin reference substance, adds methanol and make the solution that every 1ml contains 0.0204mg.
It is an amount of that the sample that embodiment 1 makes is got in the preparation of need testing solution, is ground into fine powder, and precision takes by weighing 0.5g, put in the tool plug conical flask, the accurate methanol 25ml that adds claims to decide weight, supersound extraction 60min, taking-up room temperature to be chilled to claims to decide weight, supplies the weight that subtracts mistake with methanol, shake up, filter, get filtrate, promptly.
Accurate respectively reference substance solution and each the 5 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
The result: icariin content is 2.22mg/g.
Embodiment 6 psoralen assays
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Methanol-water (45: 55) is a mobile phase; Detect wavelength 246nm.
It is an amount of that the preparation precision of reference substance solution takes by weighing the psoralen reference substance, adds methanol and make the solution that every 1ml contains psoralen 0.014mg.
It is an amount of that the sample that embodiment 1 makes is got in the preparation of need testing solution, is ground into fine powder, and precision takes by weighing 0.5g, puts in the tool plug conical flask, the accurate methanol 50ml that adds puts into supersonic generator and extracts 60min, takes out room temperature to be chilled to, and filters, the accurate filtrate 20ml that draws, evaporate to dryness, residue add water 20ml makes dissolving, uses chloroform extraction 5 times, each 20ml, combined chloroform liquid, reclaim under reduced pressure is to doing, residue makes dissolving with methanol, moves in the 25ml measuring bottle gradation washing, add methanol to scale, shake up, promptly.
Accurate respectively reference substance solution and each the 5 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
Psoralen content is 0.76mg/g as a result.
Embodiment 7 stability tests
It is indoor that embodiment 1 is made sample (aluminium plastic membrane packing) placement, and temperature 20-35 ℃, relative humidity 40%-80% deposited three months.Investigate sample character, discriminating, moisture, granularity, melting, assay and microbial limit every month one time, the results are shown in Table.The result shows that this product is through trimestral preliminarily stabilised investigation, and every index is all up to specification, tentatively shows this product steady quality.
Standing time project 0 month (August 6) January (JIUYUE 9 days) February (October 7) March (November 8)
Character Brown particle, bitter in the mouth Brown particle, bitter in the mouth Brown particle, bitter in the mouth Brown particle, bitter in the mouth
Differentiate (1) Colla cornus cervi feature speckle (2) should be detected and Fructus Psoraleae feature speckle should be detected ????+ ????+ ????+ ????+ ????+ ????+ ????+ ????+
Check Moisture granularity melting 4.31 3.2 is qualified 4.40 3.1 is qualified 4.35 3.5 is qualified 4.51 3.0 is qualified
Assay Excessive sheep flower bud glycosides content psoralen content ????2.22 ? ????0.76 ????2.18 ? ????0.81 ????2.24 ? ????0.74 ????2.27 ? ????0.78
Limit test of microbe Antibacterial mycete escherichia coli 103/g<10 do not detect 56/g<10 do not detect 100/g<10 do not detect 179/g<10 do not detect
The preparation of embodiment 8 in high spirit mixture
Get Cornu Cervi tablet 0.75kg, Herba Epimedii 1.5kg, Fructus Ligustri Lucidi 1.2kg, Fructus Psoraleae 0.9kg, Fructus Corni 0.75kg, Pericarpium Citri Reticulatae 0.75kg, the water that at every turn adds 10 times of amounts decocts three times for 100 ℃, first, second time each 1 hour, the 3rd half an hour, filter collecting decoction, 14000rps high speed centrifugation, get supernatant concentration to an amount of, add an amount of sucrose, sodium benzoate, ethyl hydroxybenzoate, boil, volume is adjusted to 5300ml, packing, sterilization promptly.Wherein icariin content is 1.25mg/ml, and psoralen is 0.26mg/ml.

Claims (1)

1, a kind of preparation method for the treatment of the Chinese medicine preparation of chronic heart failure is characterized in that this method comprises the following steps:
1) raw material weight percentage ratio prescription
Colla cornus cervi 1%-5% or Cornu Cervi tablet 8%-25%, Herba Epimedii 15%-40%, Fructus Ligustri Lucidi 15%-40%, Fructus Psoraleae 10%-30%, Fructus Corni 8%-25% and Pericarpium Citri Reticulatae 8%-25%;
2) preparation method
Get Colla cornus cervi or Cornu Cervi tablet and pulverize, cross 80 mesh sieves, standby; Getting all the other components in the prescription adds the water that 10-30 doubly measures and decocts 2-3 time for 90 ± 10 ℃, filter, collecting decoction, relative density is 1.04-1.05 when being concentrated into room temperature, the 14000-16000rps high speed centrifugation, relative density is 1.10-1.14 when getting supernatant concentration to 90 ℃, spray drying or add a small amount of dextrin spray drying and get extract powder; Above-mentioned harts horn carbon is mixed with extract powder, and adding pharmaceutic adjuvant formulation method is routinely made solid orally ingestible;
Or get in the prescription except that Colla cornus cervi each raw material and add the water that 10-30 doubly measures and decoct 2-3 time filtration, collecting decoction for 90 ± 10 ℃, the 14000-16000rps high speed centrifugation, get supernatant concentration, adding preservative agent, correctives or the Colla cornus cervi after molten are made mixture according to a conventional method.
CNB2005100240186A 2005-02-23 2005-02-23 Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure Active CN100333746C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100240186A CN100333746C (en) 2005-02-23 2005-02-23 Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100240186A CN100333746C (en) 2005-02-23 2005-02-23 Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure

Publications (2)

Publication Number Publication Date
CN1682869A true CN1682869A (en) 2005-10-19
CN100333746C CN100333746C (en) 2007-08-29

Family

ID=35262488

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100240186A Active CN100333746C (en) 2005-02-23 2005-02-23 Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure

Country Status (1)

Country Link
CN (1) CN100333746C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103705608A (en) * 2012-10-07 2014-04-09 上海中医药大学附属曙光医院 Medicine preparation used for treating chronic cardiac failure and preparing method thereof
US8839000B2 (en) 2009-03-23 2014-09-16 Hewlett-Packard Development Company, L.P. System and method for securely storing data in an electronic device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291734C (en) * 2004-04-30 2006-12-27 成都优他制药有限责任公司 Method for preparing and controlling the quality of Chinese medicinal soft capsule

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8839000B2 (en) 2009-03-23 2014-09-16 Hewlett-Packard Development Company, L.P. System and method for securely storing data in an electronic device
CN103705608A (en) * 2012-10-07 2014-04-09 上海中医药大学附属曙光医院 Medicine preparation used for treating chronic cardiac failure and preparing method thereof

Also Published As

Publication number Publication date
CN100333746C (en) 2007-08-29

Similar Documents

Publication Publication Date Title
CN100497396C (en) Dendrobium candidum polysaccharide extractive, medicine composition thereof and its preparation and use
CN101711805B (en) Medicine composition for treating rheumatoid arthritis and preparation thereof
CN102772499B (en) Effective parts obtained by alcohol extraction of raw materials of Relingqing granules as well as preparation method and applications thereof
CN101554409A (en) Long pepper alkaloid and preparation method, preparation and application thereof
CN102772500B (en) Relingqing Polygonum capitatum Buch-Ham ex D.Don raw material extract with anti-inflammatory action
CN102134268B (en) Method for preparing panax japonicus saponin IVa and application of panax japonicus saponin IVa in preparing a medicament for protecting liver and lowering transaminase
CN101428033B (en) Mix-configuration ginsenoside Rh2 and uses thereof
CN102805767B (en) Heat stranguria removal granule raw material polygonum capitatum extract with anti-gonococcus effect
CN100333746C (en) Method for preparing Chinese medicine preparation for treating chronic conjestive heart-failure
CN1775267A (en) Kaikoujian extract, Its preparing method and use
CN1709417A (en) Ainsliaea fragrans champ extract and its preparing method
CN101549010B (en) A preparing method and application of malaytea scurfpea fruit total glycosides extract
CN101214252B (en) Antiviral antibacterial medicinal composition and preparation thereof
CN1327856C (en) Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process
CN108159160B (en) Combined medicine for treating colorectal cancer
CN1264530C (en) Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process
CN101618069B (en) Capsule preparation for treating bruise as well as bleeding and easing pain and preparation method and use thereof
CN1911272A (en) Powder injection contg. high content tanshin polyphenolic acid salts, and its prepn. method
CN100502867C (en) Preparation of sinomenine as antineoplastic medicament
CN1304025C (en) Active part and effective component of Four Drug Decoction
CN1695649A (en) Soft capsule of extractive from active ingredient of jingangteng, and preparation method
CN101249129B (en) Chinese medicine extract combination and medicine use thereof
CN1857436A (en) Chinese medicine composition for clearing away and toxic material, drying damp and treating dysentery and its preparing method and application
CN100546602C (en) Anti-tumor compound polygoni cuspidati,radix, Radix Actinidiae Chinensis, Radix Gei japonici preparation and its production and application
CN107468760B (en) Application of guava leaf extract in preparing anti-rotavirus drugs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Free format text: FORMER OWNER: SHANGHAI ZHONGDA SHUGUANG PHARMACEUTICAL RESEARCH AND DEVELOPMENT CO., LTD.

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20100817

Address after: 200021 Shanghai city Pu Road No. 185

Patentee after: Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine

Address before: 200021 Shanghai city Pu Road No. 185

Co-patentee before: Shanghai University of Chinese Medicine Shuguang Medicine Research and Development Co., Ltd.

Patentee before: Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine